NEW YORK – The US Food and Drug Administration cleared in vitro diagnostic tests in December from Luminex, Microgenics, Sentinel Diagnostics, i-Sens, and others, according to the agency's website.
Austin, Texas-based tests and platforms developer Luminex got the nod for its NxTag Respiratory Pathogen Panel, a qualitative test run on the firm's Magpix instrument to simultaneously detect and identify nucleic acids from multiple respiratory viruses and bacteria.